{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:14:40Z","timestamp":1768868080417,"version":"3.49.0"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Sarcopenia (Sp) and obesity (Ob) have significant negative effects on steatotic liver disease (SLD). Here, we examined the effects of sarcopenic Ob (SO) on liver fibrosis in patients with SLD. Methods: We included 811 patients who visited our outpatient clinic and underwent FibroScan (Echosens, France). Liver stiffness (LS) was assessed using body mass index (BMI) and grip strength (GS). We conducted a similar analysis by converting the difference in estimated glomerular filtration rate (dGFR) based on creatinine and cystatin C levels into GS. Results: The cutoff values for distinguishing metabolic dysfunction-associated steatotic liver disease (MASLD; 298 patients) with LS &gt; 10 kPa (advanced fibrosis) were set separately for men and women using receiver operating characteristic analysis. BMI was set at &gt;26 kg\/m2 in women and &gt;27 kg\/m2 in men (modified Ob (mOb)), and GS was set at &lt;16 kg in women and &lt;31 kg in men (modified Sp (mSp)). The ratio of advanced fibrosis was higher in the group with both mSp and mOb (mSpOb) than in the group with mSp alone or mOb alone in MASLD or alcoholic liver disease (ALD, 97 patients). However, this association has not yet been observed in other diseases. The dGFR was used to set the cutoff value corresponding to advanced fibrosis. Sp-dGFR (SpdG) was &gt;1.14 in women and &gt;\u22120.76 in men in the MASLD group. mSpOb, SpdG and Ob are associated with advanced fibrosis in MASLD logistic regression analysis. Conclusions: SO, assessed using BMI and GS or dGFR, was associated with elevated LS in patients with SLD.<\/jats:p>","DOI":"10.3390\/diagnostics16020324","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:35:27Z","timestamp":1768822527000},"page":"324","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Sarcopenic Obesity\u2013Related Scores and Liver Fibrosis in Patients with Steatotic Liver Disease: A Cross-Sectional Study"],"prefix":"10.3390","volume":"16","author":[{"given":"Tatsuki","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"},{"name":"Department of Comprehensive Community Care Systems, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-7299","authenticated-orcid":false,"given":"Satoshi","family":"Miuma","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Yamashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Yamamichi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Koike","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Innovation and Translational Research Center, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuko","family":"Kakizoe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryusei","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nagasaki Harbor Medical Center, Nagasaki 850-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Miyaaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014Aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","article-title":"Burden of disease scenarios for 204 countries and territories, 2022\u20132050: A forecasting analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Vollset","year":"2024","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3350\/cmh.2025.0043","article-title":"Liver Disease Trends in the Asia-Pacific Region for the Next 50 Years","volume":"31","author":"Shiina","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/joim.20103","article-title":"Evaluating the prevalence and severity of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus in primary care","volume":"298","author":"Balkhed","year":"2025","journal-title":"J. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12937-025-01081-0","article-title":"Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: A study from two cohorts in China and the United States","volume":"24","author":"Zhang","year":"2025","journal-title":"Nutr. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/liv.14719","article-title":"Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease","volume":"41","author":"Hsieh","year":"2021","journal-title":"Liver Int."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, L., Zhang, J., Liu, Y., Zhou, H., Yan, W., and Ren, H. (2022). The Relationship between Health-Related Fitness and Quality of Life in Non-alcoholic Fatty Liver Disease. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192114215"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Feng, Z., Xia, J., Yu, J., Wang, J., Yin, S., Yang, J., Wu, T., Zhang, Z., Yan, W., and Wang, S. (2025). Pathophysiological Mechanisms Underlying Sarcopenia and Sarcopenic Obesity: A Systematic Review and Meta-Analysis of Biomarker Evidence. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115113"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes. Facts"},{"key":"ref_14","first-page":"997","article-title":"Diagnosis of sarcopenic obesity in Japan: Consensus statement of the Japanese Working Group on Sarcopenic Obesity","volume":"24","author":"Ishii","year":"2024","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/oby.23733","article-title":"Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography","volume":"31","author":"Cho","year":"2023","journal-title":"Obesity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s10620-025-08844-z","article-title":"Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)","volume":"70","author":"Chien","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","first-page":"1183","article-title":"Identification of Candidates for MASLD Treatment with Indeterminate Vibration-Controlled Transient Elastography","volume":"23","author":"Siddiqi","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jhep.2024.03.015","article-title":"Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure","volume":"81","author":"Semmler","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2024.05.008","article-title":"Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD","volume":"81","author":"Gawrieh","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/hepr.14039","article-title":"Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease","volume":"54","author":"Nouso","year":"2024","journal-title":"Hepatol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2021.08.030","article-title":"An elevated FIB-4 score predicts liver cancer development: A longitudinal analysis from 29,999 patients with NAFLD","volume":"76","author":"Loosen","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index","volume":"45","author":"Kashani","year":"2016","journal-title":"Crit. Care Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kim, S.W., Jung, H.W., Kim, C.H., Kim, K.I., Chin, H.J., and Lee, H. (2016). A new equation to estimate muscle mass from creatinine and cystatin C. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148495"},{"key":"ref_25","first-page":"89","article-title":"Indices calculated by serum creatinine and cystatin C as predictors of liver damage, muscle strength and sarcopenia in liver disease","volume":"12","author":"Ichikawa","year":"2020","journal-title":"Biomed. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/hepr.13492","article-title":"Calculated body muscle mass as a useful screening marker for low skeleton muscle mass and sarcopenia in chronic liver disease","volume":"50","author":"Ichikawa","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_29","first-page":"55","article-title":"Sarcopenia: The Target Population","volume":"2","author":"Malmstrom","year":"2013","journal-title":"J. Frailty Aging"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/hepr.13679","article-title":"Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan","volume":"51","author":"Nishikawa","year":"2021","journal-title":"Hepatol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_32","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl. Clin. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hepr.12774","article-title":"Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.jhepr.2022.100663","article-title":"Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD","volume":"5","author":"Linge","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jcsm.12834","article-title":"Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study","volume":"12","author":"Linge","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/jcsm.13586","article-title":"Factors associated with handgrip strength across the life course: A systematic review","volume":"15","author":"Ribeiro","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/liv.15498","article-title":"Muscle strength in non-alcoholic fatty liver disease and specific mortality","volume":"43","author":"Kim","year":"2022","journal-title":"Liver Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.clnu.2023.02.018","article-title":"Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI)\u2014Proceedings from the SOGLI consortium meeting in Rome November 2022","volume":"42","author":"Guillet","year":"2023","journal-title":"Clin. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, T., Zhu, Y., Liu, X., Zhang, Y., Zhang, Z., Wu, J., Huang, G., and Xu, J. (2024). Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19137-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clnesp.2022.07.010","article-title":"Relationship between the creatinine\/cystatin C ratio and muscle mass measured by CT-scan in cancer patients","volume":"51","author":"Tlemsani","year":"2022","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2018.12.030","article-title":"Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex","volume":"70","author":"Yoo","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"sfaf003","DOI":"10.1093\/ckj\/sfaf003","article-title":"Discordance between cystatin C-based and creatinine-based estimated glomerular filtration rate and health outcomes in adults: A systematic review and meta-analysis","volume":"18","author":"Liu","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/dci25-0029","article-title":"Mind the Gap: Discordance Between Cystatin C and Creatinine eGFR and Diabetes Complications","volume":"48","author":"MacIsaac","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100710","DOI":"10.1016\/j.xkme.2023.100710","article-title":"Discordance Between Creatinine-Based and Cystatin C\u2013Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR","volume":"5","author":"Wang","year":"2023","journal-title":"Kidney Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.ajkd.2025.03.018","article-title":"Complex Etiologies of the Discordance Between Cystatin C\u2013 and Creatinine-Based Estimated GFR and Its Adverse Associations: Findings from the CRIC Study","volume":"86","author":"McCoy","year":"2025","journal-title":"Am. J. Kidney Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction\u2013Associated Steatotic Liver Disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1016\/j.jnha.2025.100652","article-title":"Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity?","volume":"29","author":"Prokopidis","year":"2025","journal-title":"J. Nutr. Health Aging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/d41586-025-00404-9","article-title":"Dozens of new obesity drugs are coming: These are the ones to watch","volume":"638","author":"Elie","year":"2025","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ijo.0803483","article-title":"Changes in fat-free mass during significant weight loss: A systematic review","volume":"31","author":"Chaston","year":"2007","journal-title":"Int. J. Obes."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22493","article-title":"Weight Cycling as a Risk Factor for Low Muscle Mass and Strength in a Population of Males and Females with Obesity","volume":"27","author":"Rossi","year":"2019","journal-title":"Obesity"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101696","DOI":"10.1016\/j.arr.2022.101696","article-title":"Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk","volume":"80","author":"Kuchay","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.24624","article-title":"Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients","volume":"55","author":"Myers","year":"2012","journal-title":"Hepatology"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/2\/324\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:45:34Z","timestamp":1768823134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/2\/324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["diagnostics16020324"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16020324","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]}}}